• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

IVI Launches 2-Year Health Equity Initiative

Article

The Innovation and Value Initiative (IVI) announced the launch of its Health Equity Initiative, a 2-year initiative that aims to define gaps in value assessment methodology and develop best practices that support health equity.

Alexandria, Virginia — The Innovation and Value Initiative (IVI) announced the launch of its Health Equity Initiative, a 2-year initiative that aims to define gaps in value assessment methodology and develop best practices that support health equity.

The IVI Health Equity Initiative’s goals include:

  1. Advancing our understanding of why health equity considerations in value assessment are important
  2. Identifying gaps in data collection and methods practices and implications related to health equity
  3. Developing “best practice” protocols that inform the practice of value assessment and health technology assessment (HTA) to mitigate these gaps
  4. Achieving multi-stakeholder consensus about areas for further research, scientific practice change, and policy development

“Through this work, IVI has found that without a consistent and intentional focus on equity, we are blind to key differences among patients. Also, current assessments run the risk of reinforcing or even exacerbating inequities that already exist in the US health care system,” noted Rick Chapman, PhD, chief science officer, IVI.

Learn more.

Related Videos
Chase D. Hendrickson, MD, MPH
Takiyah Durham, MBA, and Margaret Larkins-Pettigrew, MD
Afreen Idris Shariff, MD, MBBS, Duke Cancer Institute
 Brian Mullen, PhD, head of innovation and product, The Clinic by Cleveland Clinic
Mike Koroscik, MBA, MHA, Allina Health and the Allina Health Cancer Institute
Ted Okon, MBA, Community Oncology Alliance
dr erin gillaspie
Miriam J. Atkins, MD, FACP, Community Oncology Alliance/AO Multispecialty Clinic
Lalan Wilfongd, MD, US Oncology Network
Related Content
© 2023 MJH Life Sciences
AJMC®
All rights reserved.